⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Atossa Therapeutics, Inc. Common Stock

$1.65
-0.11 (-6.25%)

Volume:

46.422K ($74.08K)

Market Capitalization:

$16.47M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Atossa Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

+0.06(+3.45%)
Open$1.60
Close$1.65
Low$1.60
Low Change0.00 (0.00%)
High$1.65
High Change+0.06 (+3.45%)
Range$0.06
Volume655
Dollar Volume$1.08K

Regular Trading Hours

-0.13(-7.27%)
Open$1.72
Close$1.60
Low$1.59
Low Change-0.13 (-7.56%)
High$1.72
High Change+0.00 (+0.00%)
Range$0.13
Volume45.767K
Dollar Volume$73.00K

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$1.75
Close$1.75
Low$1.75
Low Change0.00 (0.00%)
High$1.75
High Change+0.00 (+0.00%)
Range$0.00
Volume1.234K
Dollar Volume$2.16K

Regular Trading Hours Yesterday

-0.07(-3.83%)
Open$1.83
Close$1.76
Low$1.75
Low Change-0.08 (-4.37%)
High$1.85
High Change+0.02 (+1.09%)
Range$0.10
Volume22.74K
Dollar Volume$40.02K

Premarket Yesterday

*No Trades in Segment

Atossa Therapeutics Top Trades

Atossa Therapeutics's top trade so far today returned +3.77%, while the top short trade returned -7.56%.

Atossa Therapeutics Moving Averages

5 Day Moving Average (SMA5)$1.87
10 Day Moving Average (SMA10)$1.98
20 Day Moving Average (SMA20)$2.13
50 Day Moving Average (SMA50)$2.28
100 Day Moving Average (SMA100)$2.36
200 Day Moving Average (SMA200)$3.49

Atossa Therapeutics Statistics

Average Volume (30 Days)82.42K
P/E Ratio (Current)-.52
EPS (Current)-$3.47
Dividend Yield0.00%
Free Cash Flow-$35.29M
Cash Ratio4.37
Current Ratio5.35
Quick Ratio4.71
Debt to Equity0.00
Enterprise Value-$2.51M
EV to EBITDA0.07
EV to Sales—
Price to Book0.83
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-1.31%
Return on Equity-1.59%

Atossa Therapeutics Stock Splits

There have been 3 stock splits for Atossa Therapeutics (ATOS). The last reverse stock split occured on February 2, 2026 and reduced the outstanding shares at a ratio of 15:1.

DateTypeRatio
Feb 2, 2026Reverse15:1
Apr 20, 2018Reverse12:1
Aug 26, 2016Reverse15:1

Atossa Therapeutics Dividends

There have been no dividends for Atossa Therapeutics (ATOS).